Abstract
At the culmination of poliovirus (PV) multiplication, membranes are observed that contain phosphatidylinositol-4-phosphate (PI4P) and appear as vesicular clusters in cross section. Induction and remodeling of PI4P and membranes prior to or concurrent with genome replication has not been well studied. Here, we exploit two PV mutants, termed EG and GG, which exhibit aberrant proteolytic processing of the P3 precursor that substantially delays the onset of genome replication and/or impairs virus assembly, to illuminate the pathway of formation of PV-induced membranous structures. For WT PV, changes to the PI4P pool were observed as early as 30 min post-infection. PI4P remodeling occurred even in the presence of guanidine hydrochloride, a replication inhibitor, and was accompanied by formation of membrane tubules throughout the cytoplasm. Vesicular clusters appeared in the perinuclear region of the cell at 3 h post-infection, a time too slow for these structures to be responsible for genome replication. Delays in the onset of genome replication observed for EG and GG PVs were similar to the delays in virus-induced remodeling of PI4P pools, consistent with PI4P serving as a marker of the genome-replication organelle. GG PV was unable to convert virus-induced tubules into vesicular clusters, perhaps explaining the nearly 5-log reduction in infectious virus produced by this mutant. Our results are consistent with PV inducing temporally distinct membranous structures (organelles) for genome replication (tubules) and virus assembly (vesicular clusters). We suggest that the pace of formation, spatiotemporal dynamics, and the efficiency of the replication-to-assembly-organelle conversion may be set by both the rate of P3 polyprotein processing and the capacity for P3 processing to yield 3AB and/or 3CD proteins.
Author summary
All positive-strand RNA viruses replicate their genomes in association with host cell membranes. PV does not just remodel existing membranes, but induces membranes with unique structure and lipid composition. There has been some suggestion that the functions of the PV-induced structures observed during infection may not be those that perform genome replication. This study uses kinetic analysis and kinetic traps of virus-induced membrane formation/transformation and PI4P induction by WT PV and two PV mutants to provide evidence for the existence of a virus-induced genome-replication organelle temporally and spatially distinct from a virus-assembly organelle. In addition, our studies suggest that formation of both organelles may require participation of viral proteins, 3AB and/or 3CD. Therefore, this study provides a new perspective on the cell biology of PV infection and should inspire a fresh look at picornavirus-induced organelles, their functions and the role of P3 proteins in their formation and interconversion.
Introduction
Positive-strand RNA viruses pose a great threat to public health because of their simplicity and evolvability [1]. Introduction of a modestly-sized, mRNA-sense genome is sufficient to commandeer the cell, establish infection and produce thousands of progeny in a matter of only hours. Among the least understood aspect of positive-strand RNA virus biology is the eclipse phase of the life cycle, the events post-entry but prior to exponential amplification of the genome and assembly of infectious virus. We use poliovirus (PV), the type virus in the Enterovirus genus of the Picornaviridae family of viruses, as our model system. Establishment of infection by PV likely requires entry of multiple genomes into the cell [2,3]. This circumstance may be required to permit translation of infecting virion RNA to produce viral protein in sufficient quantity to overwhelm host defenses that might otherwise curtail infection and to hijack host factors essential to initiate a productive infection. It is becoming increasingly clear that picornaviruses have evolved mechanisms to increase multiplicity of infection, for example by leaving cells in vesicles and perhaps entering that way [4,5] or by attaching to bacterial surface polysaccharides and entering in association with these organisms [6].
Another important function of viral proteins produced during the eclipse phase is establishment of sites of genome replication. All positive-strand RNA viruses replicate in association with membranes; three general strategies exist [7]. The first strategy is to commandeer an organellar membrane by directing viral proteins to the organelle. Binding of the viral protein will induce invaginations with negative curvature from the perspective of the cytoplasm that have been termed spherules. In response to actions of the same or different viral proteins, the lipid and protein composition of the spherules may be remodeled to reflect the genome-replication needs of the virus. The second strategy uses a two-step process. The virus commandeers vesicular and/or organellar membranes, again by directing viral proteins to their membranes. Hijacked membranes are then forced into a new form by remodeling lipid and/or protein composition to create a virus-induced organelle best suited to genome replication. The third strategy is a blend of the first two. Localize first to an organelle and later induce a virus-specific organelle(s), which may be the case for enteroviruses [8].
Since the earliest studies of PV-infected cells using transmission electron microscopy (TEM), it has been well documented that PV infection wreaks havoc on intracellular membranes, for example causing dissolution of the Golgi apparatus (referred to throughout as Golgi), to create membranes of unique benefit to the virus [9–13]. PV-induced membranes often appear as clusters of vesicles by TEM. These structures have been shown to contain viral RNA and proteins [14–17]. More recent studies by Ehrenfeld, Belov and colleagues using electron tomography have suggested that PV-induced membranes arise from tubules [9]. The thought is that viral or viral-hijacked proteins induce invaginations of positive curvature and promote folding of tubules, which would appear as vesicular clusters in cross section. In the Ehrenfeld and Belov study, a kinetic analysis was performed that provided the first suggestion that the most dramatic PV-induced changes to membranes occurred after genome-replication was well underway, if not completed.
Prior to the tomography study, Altan-Bonnet and colleagues showed induction of phosphatidylinositol-4-phosphate (PI4P) by another member of the Enterovirus genus, Coxsackievirus B3 (CVB3) [18]. In uninfected cells, PI4P localizes to the Golgi. During infection, PI4P starts at the Golgi then relocalizes to a site between the endoplasmic reticulum (ER) and Golgi, perhaps the ER-Golgi intermediate compartment (ERGIC). At later times post-infection, PI4P fills the entire perinuclear region of the cell and now localizes with ER markers. During the entire infection period, PI4P localizes with viral RNA and proteins. One conclusion of the study was that PI4P is a marker of the PV-induced organelle. When considered in the context of the tomography study, it is possible that the perinuclear PI4P observed for CVB3 reflects the invaginated and folded tubules observed for PV that might not function in genome replication. Therefore, the earliest stages of PI4P induction and membrane remodeling may actually represent the replication organelle, for which TEM images are not available.
The large polyprotein encoded by the PV genome can be divided into three smaller precursor proteins: P1, P2 and P3 (Fig 1A) [19]. P1 proteins form the capsid. P2 proteins are thought to be the most functionally diverse of the PV proteins as these proteins shut off host cell pathways, derange host cell membranes, function in genome replication and genome encapsidation, and can even leave their mark on the encapsidated genome by somehow controlling its uncoating [13,16,20–31]. P3 proteins are most intimately associated with genome replication as these proteins bind to the genome and catalyze RNA synthesis [32–38].
PV uses differential cleavage of the polyprotein as one mechanism to expand its proteome. Cleavage of the P3 precursor protein is mediated by the 3C-encoded protease activity. This protease cleaves at Gln-Gly junctions, but the requirements for cleavage extend beyond a single dipeptide [39–41]. Two pathways exist for cleavage of P3 [42,43]. The major pathway produces only two proteins: 3AB and 3CD (Fig 1B). The minor pathway is more complex. First, P3 is cleaved to produce 3A and 3BCD proteins. 3BCD is then cleaved to produce 3BC and 3D. Finally, 3BC is cleaved to produce 3B (also known as VPg, virion protein linked to the genome) and 3C.
Previously, we reported two PV mutants in which the cleavage site between 3B and 3C was changed to Gly-Gly (GG PV) [43] or Glu-Gly (EG PV) [43,44]. For GG PV, the products of the major pathway were 3ABC and 3D, thus ablating the production of both 3AB and 3CD (see GG in Fig 1B). With the exception of 3BC, which cannot be cleaved, products of the minor pathway were essentially unchanged [43]. For EG PV, the products of both pathways were the same as observed for wild type (WT) (see EG in Fig 1B). However, the rate of cleavage at the 3BC junction was reduced, causing a reduced rate of accumulation of 3AB and 3CD. Both mutants exhibited what appeared to be a reduced rate of genome replication. For EG PV, ectopic expression of 3CD alone corrected this phenotype, consistent with the phenotype arising solely from the reduced rate of 3CD production. In addition to the impact on genome yield, GG PV exhibited a near-complete loss of infectious virus. Neither of the GG PV phenotypes could be suppressed by ectopic expression of 3CD.
The extended duration of the eclipse phase observed for EG PV and the defect to virus assembly observed for GG PV provided a unique opportunity to expand our understanding of these steps of the virus lifecycle at the molecular and ultrastructural levels. We find that there is a clear temporal ordering of PI4P induction, and its initial induction and limited redistribution exhibit the expected kinetics for an organelle involved in genome replication. We trapped the earliest intermediates in the biogenesis of the genome-replication organelle using the replication inhibitor, guanidine hydrochloride. The earliest events include remodeling of PI4P and proliferation of tubular membranes. Later, Golgi fragments and ERGIC expands. It is only after genome replication is near completion that the perinuclear region of the cell becomes filled with vesicular clusters. At the same stage of virus multiplication that vesicular clusters predominate for WT PV, tubules predominate for GG PV. The inability of GG PV to assemble infectious virus is consistent with the possibility that vesicular clusters contribute substantively to steps after genome replication on path to production of infectious virus. The defect in transformation of tubules (genome-replication organelle) into vesicular clusters (virus-assembly organelle) may arise from the inability of the GG-derived P3 proteins (3ABC and/or 3D) to contribute to interactions with host and/or viral factors. We propose that two organelles are induced during PV infection that serve temporally distinct functions during the PV lifecycle and that P3-encoded proteins (3AB and/or 3CD) contribute to formation and function of both.
Results
Delayed release of 3AB and 3CD proteins from the P3 precursor protein delays onset of genome replication
Our previous studies of EG PV showed that its genome-replication defect could be complemented in trans by expression of 3CD [44]. This observation was unexpected because numerous studies have shown that genome-replication defects can only be complemented in trans by expression of P3 or P2-P3 polyproteins, if at all [45–47]. Our study used a subgenomic replicon in which P1-coding sequence had been replaced with firefly luciferase-coding sequence, and replication was monitored indirectly by measuring luciferase activity. It was possible that measuring luciferase activity instead of RNA confounded our interpretation of the experiment.
To test this possibility, we transfected WT or EG PV subgenomic replicon RNA into HeLa cells. We monitored RNA synthesis either by measuring luciferase activity (Fig 2A) or by measuring positive-sense RNA using Northern blotting (Fig 2B and 2C). We observed three discernible phases of luciferase activity for WT: 0–2 h, 2–5 h, and 5–10 h; and for EG: 0–3 h, 3–7 h and 7–10 h (Fig 2A and S1 Fig). In contrast, we observed only one phase of RNA accumulation for both (Fig 2B and S1 Fig). Translation of replicon RNA occurs during the lag phase of RNA synthesis monitored by Northern blotting (0–2 h for WT and 0–3 for EG, Fig 2 and S1 Fig), thus adding a phase to the kinetics of RNA synthesis monitored by luciferase activity. There is also an additional phase near the end of the time course that is observed when measured by luciferase activity, where a plateau is observed when measured by Northern blotting (5–10 h for WT and 7–10 for EG, Fig 2 and S1 Fig). WT RNA accumulation began between 2–3 h post-transfection; EG RNA accumulation began between 3–4 h post-transfection (Fig 2B). We conclude that a delay of two hours in the onset of replicon RNA replication can be obscured by monitoring luciferase activity. Luciferase activity concealed the delay. Translation of transfected replicon RNA produced luciferase activity for at least two hours in the presence of guanidine hydrochloride (GuHCl), a replication inhibitor, and therefore without the need for replicon RNA replication (see WT +GuHCl in Fig 2A). These results support the hypothesis that delayed kinetics of P3 precursor processing to form 3AB and 3CD in cells causes a delay in a step preceding the onset of RNA synthesis.
Kinetics of formation of PV-induced vesicular clusters are inconsistent with these structures serving as the sites of genome replication
A hallmark of PV-infected cells as observed by transmission electron microscopy (TEM) is the presence of vesicular clusters [9,13]. These vesicular clusters are also referred to as replication complexes or replication organelles. Given the accepted role of these vesicular clusters in genome replication, we reasoned that formation of these structures should occur either prior to the onset of genome replication or concomitant with genome replication. Formation and/or function of these structures could therefore represent the pre-genome-replication step perturbed for EG PV.
We infected HeLa cells with EG PV and then at various times post-infection processed samples to measure genomic RNA by Northern blotting (Fig 3A and 3B), to measure infectious virus by plaque assay (Fig 3A) and to visualize formation of the vesicular clusters by TEM (Fig 3C). The exponential phase of genome replication occurred between 2 h and 6 h post-infection (Fig 3A and 3B). The exponential phase of infectious virus production occurred between 4 h and 8 h post-infection (Fig 3A). Vesicular clusters became visible at 4 h post-infection and continued to increase in abundance and/or change in organization throughout the 7 h time course (Fig 3C). Formation of vesicular clusters neither preceded genome replication nor occurred concomitant with genome replication as expected for an organelle responsible for genome replication. In contrast, formation of vesicular clusters preceded infectious virus production.
The delay in induction of the vesicular clusters by EG PV provided a unique opportunity to monitor the early steps in formation of these structures. In uninfected cells, it was very easy to observe mitochondria and Golgi. However, closer inspection was required to observe the tubules of the endoplasmic reticulum (ER) (uninfected (UN) in Fig 3C). By 2 h post-infection, the density of mitochondria had diminished (2 h in Fig 3C). Golgi stacks were fragmented and swollen, and tubules easy to visualize (2 h in Fig 3C). At 3 h post-infection, much of the Golgi had disappeared (3 h in Fig 3C). The area between the remaining Golgi and the now very swollen ER was filled with very small vesicles that may be the ever-expanding ERGIC caused by the loss of the Golgi (3 h in Fig 3C) [18]. At 4 h post-infection, vesicular clusters were first observed (4 h in Fig 3C). These vesicular clusters appear to be encased by tubules (4 h in Fig 3C). Vesicular clusters continue to accumulate to at least 7 h post-infection (5 h and 7h in Fig 3C).
In order to make certain that our observations above were not unique to the mutant virus, we repeated the experiment using WT PV (Fig 4). The exponential phase of genome replication occurred between 1 h and 5 h post-infection (Fig 4A and 4B). The exponential phase of infectious virus production occurred between 3 h and 7 h post-infection (Fig 4A). Vesicular clusters were now clearly visible at 3 h post-infection and again continued to increase in abundance or change in organization throughout the 7 h time course (Fig 4C). Many of the early steps described for EG PV could not be observed for wild type because they occurred so soon post-infection that we could not process the cells fast enough to capture images of these steps by TEM.
In addition to the temporal difference in the formation of the vesicular clusters observed for EG PV and WT PV, differences also existed in the overall size, interaction and localization of these structures (compare 5 h for EG PV in Fig 3C to 4 h for WT PV in Fig 4C). Relative to EG PV, vesicular clusters induced by WT PV appeared larger, clustered more tightly and were far more constrained to the perinuclear region of the cell.
Both experiments were consistent with the surprising finding that the kinetics of formation of the PV-induced vesicular clusters are inconsistent with these structures serving as the genome-replication organelle. These structures became easily identifiable two hours after genome replication began (4 h for EG PV in Fig 3C; 3 h for WT PV in Fig 4C). Interestingly, and perhaps coincidentally, this was the time after genome replication began that we were able to detect infectious virus by plaque assay (Figs 3A and 4A).
Kinetics of PI4P induction are consistent with this phosphoinositide demarcating the sites of genome replication
Coxsackievirus B3 (CVB3) infection induces PI4P, and this phosphoinositide is a component of a virus-induced organelle [18]. PI4P co-localizes with viral non-structural proteins and RNA [18]. Whether or not PI4P localizes to the virus-induced vesicular clusters is not known. Given our results, it is possible that the virus-induced PI4P localizes to membranes other than those observed by TEM well after genome replication has begun.
Although it is assumed that PV infection induces PI4P based on the data for CVB3, PI4P induction by PV has never been reported. We infected HeLa cells with WT PV or EG PV and measured PI4P as a function of time post-infection by immunofluorescence microscopy (IFM) (Fig 5). We used an antibody specific for PI4P to detect this phosphoinositide.
It is well known that most PI4P in the cell localizes to the Golgi, giving rise to very nice staining with anti-PI4P antibody (mock in Fig 5A) [18]. For WT PV, induction and redistribution of Golgi-localized PI4P was evident as early as 30 min post-infection (WT in Fig 5B). Both redistribution and induction continued to 3 h post-infection, the last time point evaluated (WT in Fig 5B). Observations with EG PV were essentially identical, except for a one-hour delay of the changes relative to wild type (EG in Fig 5B). The kinetics of induction and redistribution of PI4P were consistent with a structure responsible for genome replication. Given the TEM experiments reported above (Figs 3C and 4C), it is now clear that the PI4P-containing membranes observed by IFM prior to two hours post-infection (Fig 5B) must be temporally distinct from the large vesicular clusters that appear after genome replication (Figs 3 and 4).
PI4P induction and redistribution during WT PV infection occurred as fast as we could reliably process our cells for imaging. This observation suggested to us that viral proteins made by translation of infecting viral RNA might be sufficient to initiate PI4P remodeling. We infected cells with WT or EG PV in the presence of the genome-replication inhibitor, GuHCl. Under these conditions, the only event that can occur is translation of the infecting genomes (S2 Fig). PI4P induction and redistribution occurred in the presence of GuHCl for both WT (WT+GuHCl in Fig 5C) and EG (EG+GuHCl in Fig 5C) PVs. GuHCl did not have an impact on PI4P localization in the absence of infection (Mock+GuHCl in Fig 5C).
Dissolution of the Golgi is not inextricably linked to induction and/or redistribution of PI4P
It is well known that PV infection causes dissolution of the Golgi [48]. Changes in the organization of the Golgi were evident when we compared Giantin staining in mock-infected cells (Fig 6A) to that in WT PV-infected cells (Fig 6B) or EG PV-infected cells (Fig 6C) at 2 h or 3 h post-infection, respectively. Our ability to observe induction and redistribution of PI4P when genome replication is inhibited by GuHCl, permitted us to determine if the observed changes to PI4P were sufficient to perturb Golgi integrity. The presence of GuHCl did not impact the Golgi (Fig 6D). Interestingly, the presence of GuHCl prevented Golgi dissolution in all WT PV-infected cells (Fig 6E) and EG PV-infected cells (Fig 6F) at 2 h or 3 h post-infection, respectively. At these times post-infection, the level of PI4P had reached a maximum and was located at sites other than the Golgi. At later times post-infection, changes to Golgi were observed in some cells for both viruses (6 hpi in Fig 6E and 7 hpi in Fig 6F). However, these phenotypes were much less severe than those observed in the absence of GuHCl. We conclude that perturbations to Golgi integrity are not a direct, immediate consequence to the level or location of PI4P in the cell.
PV-induced tubules may represent the initial site of genome replication, the genome-replication organelle
The ability of PV to induce PI4P in the presence of GuHCl prompted us to use GuHCl to trap PI4P-containing membranes for interrogation by TEM. Growth of HeLa cells in the presence of 3 mM GuHCl caused no discernible perturbation to the ultrastructure of the cell (Fig 7A). In contrast, HeLa cells infected with PV in the presence of GuHCl accumulated tubular-reticular structures, referred to collectively as tubules, in the perinuclear region of the infected cells (Fig 7B). Tubules could be classified into three categories. The first category appeared as filaments in close apposition to the nuclear envelope; these may be tubules that fail to stain for reasons that are unclear (panel i, Fig 7B). The second category appeared as a reticular network well distributed throughout the perinuclear region of the cell (panel ii, Fig 7B). The third category appeared as spooled tubules (panel iii, Fig 7B). The existence of one category of tubule did not preclude the presence of another category of tubule. However, the entirety of the perinuclear region contained tubules.
PV-induced vesicular clusters as sites of virus assembly, an assembly organelle?
The studies reported above suggested that PI4P was a marker for the PV genome-replication organelle. These studies also suggested that PI4P-containing structures observed early are distinct from PV-induced vesicular clusters and are tubular in morphology. Now the question was: what is the function of the vesicular clusters? One possibility was that the vesicular clusters are structures required for virus assembly, an assembly organelle, as suggested previously by Belov and Ehrenfeld [9]. Another possibility was that the vesicular clusters are structures that represent accumulated, unused and unwanted viral proteins and nucleic acids, a viral trash compacter.
GG PV replicated to within one log of wild type but exhibited a near 5-log reduction in the amount of infectious virus produced [43]. We reasoned that this mutant might help us identify the function of the PV-induced vesicular clusters. If the vesicular clusters contribute to virus assembly, then these structures might be perturbed in cells infected with the assembly-defective GG PV. Conversely, if the vesicular clusters function as a means to consolidate viral waste, then these structures might appear unchanged in cells infected with GG PV.
We transfected HeLa cells simultaneously with two subgenomic replicons, one expressing luciferase and the other expressing EGFP. Transfected cells were then grown in suspension culture and harvested hourly to monitor luciferase activity and EGFP fluorescence. Luciferase specific activity, measured as relative light units (RLU) per microgram of protein in the extract, was plotted as a function of time for WT and GG replicons (Fig 8A). We were particularly interested in 5 h post-transfection for WT as vesicular clusters reached their maximum level at that time (Fig 4C). At 5 h post-transfection of the WT replicon combination, the luciferase specific activity was approximately 104 RLU/μg (Fig 8A). We observed the equivalent luciferase specific activity at 14 h post-transfection of the GG replicon combination (Fig 8A). Based on this result, we concluded that 5 h and 14 h post-transfection represented equivalent extents of the infection process for WT and GG PVs, respectively.
We used fluorescence activated cell sorting (FACS) to isolate transfected cells based on EGFP expression. Cells replicating WT or GG EGFP-replicon RNA before and after sorting are shown in Fig 8B. We used the EGFP-expressing, sorted cells for TEM (Fig 8C). Vesicular clusters were readily apparent in images of WT replicon-transfected cells, and these clusters were of the same overall appearance as observed using infected cells that did not require sorting (Fig 4C). In contrast, vesicular clusters were few or absent in images of GG replicon-transfected cells (Fig 8C). Instead, we observed a tubular-reticular network (arrowheads label tubules in enlargement of panel GG in Fig 8C) as observed above for WT PV in the presence of GuHCl (Fig 7B).
These results support the hypothesis that vesicular clusters function as an assembly organelle, and the absence of these structures in GG PV contribute to the defect in virus production. We propose that the tubular-reticular network is both the genome-replication organelle and an intermediate on the pathway to formation of the vesicular clusters, which are the virus-assembly organelle. These structures were apparent between 2 h and 4 h post-infection for EG PV (Fig 3C) but occurred too early to be observed for WT PV (Fig 4C). The tubules appeared to fold in on themselves, creating the vesicular clusters (see for example 4 hpi for EG PV in Fig 3C or 3 hpi for WT PV in Fig 4C). Formation of tubules and their transformation into a net-like array of vesicles has been observed before [9]. Additional studies will be required to further clarify the relationship between the tubular-reticular network in GG PV and the vesicular clusters in EG PV and WT PV.
We also assessed formation of the PI4P-marked structures by GG PV RNA. We transfected HeLa cells with GG PV EGFP-expressing, subgenomic replicon RNA and used IFM to monitor the spatiotemporal dynamics of PI4P. Redistribution and induction of PI4P occurred substantially slower than observed for EG PV or WT PV (compare Fig 8D to Fig 5). Nevertheless, temporal dynamics of PI4P explains the 8 h or so pre-genome-replication phase observed previously for GG PV [43,44]. These data are consistent with PI4P demarcating the replication organelle and a requirement for induction of this structure prior to the onset of genome replication.
Failure of GG PV to induce vesicular clusters is caused by the form(s) of P3 proteins produced but not their amount
We have argued that the inability of GG PV to produce 3AB and 3CD causes the defect to formation of vesicular clusters. The possibility existed that the accumulation of tubules in GG PV-infected cells was caused by the 4-fold reduction in the magnitude of replication and corresponding 4-fold reduction in viral proteins produced (Fig 8A). To address this question directly, we made use of 5-nitrocytidine (5-NC), an inhibitor of the PV RNA-dependent RNA polymerase that exhibits a more profound effect on the kinetics of genome replication than the magnitude of genomes produced [49]. As shown in Fig 9A, replication of the subgenomic replicon is hampered substantially in the presence of 5-NC. At 7 h post-transfection, luciferase activity is reduced by 40 fold in the presence of 5-NC; this difference narrows to only 3 fold by 12 h post-transfection (Fig 9A). Comparison of the corresponding ultrastructure in the absence and presence of 5-NC at 7 h post-infection revealed vesicular-tubular structures under both conditions (Fig 9B). We conclude that the level of PV non-structural proteins can be reduced as much as 40 fold without any consequence to formation of vesicular clusters.
In a complementary experiment, we transfected HeLa cells with mRNA produced in vitro that encodes a GFP-2BCP3 polyprotein with either a Gln-Gly 3C protease cleavage site at the 3B-3C junction (WT) or Gly-Gly at that junction (GG). GFP is separated from 2B by a linker that culminates in a 3C protease cleavage site designed to maintain an authentic 2B amino terminus. Expression of the transfected mRNA yielded similar levels of both polyproteins based on Western blots evaluating 2C protein (Fig 9C). We chose 2C protein to avoid confusion associated with the differences in the forms of P3 proteins produced by GG when compared to WT [43,44]. We used TEM to evaluate the ultrastructural changes induced by the two polyproteins (Fig 9D). Vesicular-tubular arrays were observed in cells expressing the WT polyprotein (panel GFP-2BCP3-WT in Fig 9D). In contrast, tubules were observed in cells expressing the GG polyprotein (panel GFP-2BCP3-GG in Fig 9D). Both the vesicular clusters and the tubules are smaller than observed when replication occurs (compare Fig 9D to Fig 8C). This difference may reflect the lower level of proteins produced in these experiment when compared to that produced by infection (Fig 9C). What is clear, however, is that the only explanation for the differences observed between WT and GG-induced membranes is the inability of GG to produce 3AB and/or 3CD [43,44].
High multiplicity of infection exaggerates spatiotemporal dynamics of vesicular clusters
The spatiotemporal dynamics of WT PV-induced vesicular clusters reported here were different than observed previously by others [9,11,15]. In particular, the size of the clusters was smaller, and the density of the clusters was lower (Fig 4C) than previously reported. In these earlier experiments, multiplicity of infection ranged from 30–50, but this study used 10. Because translation of the infecting genomes is sufficient to begin the remodeling process, it was possible that elevated levels of protein produced at the higher multiplicities of infection might impact the size of the clusters. To address this possibility, we infected HeLa cells with WT PV at a multiplicity of 10, 50 or 100 and processed the infected cells for TEM at 3 h post-infection. This time point was chosen because of the modest density of the vesicular clusters observed at a multiplicity of infection of 10 (Fig 4C) and should make any observed differences more noticeable. Note that virus yield (PFU/mL) is not significantly different when using MOIs from 10 to 100 (S3 Fig). As shown in Fig 10, the size of the vesicular cluster at the level of each “vesicle” and in terms of the area of the perinuclear region occupied by the vesicular clusters scaled directly with the multiplicity of infection. Therefore, it is imperative to consider multiplicity of infection when comparing micrographs.
Discussion
This study was inspired by our observation that ectopic expression of PV 3CD protein was sufficient to complement a genome-replication defect of the EG PV mutant, which exhibited a delay in processing of the P3 precursor protein [44]. The rule of thumb for PV and other picornaviruses is that non-structural proteins used to replicate a genome are produced in cis—that is, by that genome or by one in the same replication complex [45–47]. However, it became clear that the genome-replication defect was actually a defect at steps preceding genome replication (Fig 2B). The confusion was caused by the multiphasic kinetics of reporter activity produced by a subgenomic replicon (Fig 2A). The first phase of activity requires only translation of the transfected replicon. The second phase requires replicon replication. The third phase appears to be translation of replicated replicon RNA that would normally be packaged if capsid proteins had been present.
Once we knew that EG PV impaired steps leading up to genome replication, we turned our focus to formation of the “replication organelle.” Since the first TEM images of PV-infected cells were published [12], multiple reports have shown that a hallmark of PV infection is the induction of membranous structures [9–11,13]. These structures have many names: replication complexes, vesicular clusters, tubules and replication organelle. Most of the early studies searching for viral factors contributing to formation of PV-induced membranes implicated P2 proteins in this process [14,16]. The most convincing experiment showed that expression of the 2BC precursor proteins was sufficient to induce membranes with the same buoyant density and appearance by TEM as those observed during PV infection [28,29]. As a result, it was unclear how processing of the P3 precursor to form 3AB and 3CD contributed to formation of the replication organelle. However, because this structure should form before or concomitant with genome replication, it was possible that this step could be complemented in trans. 3A is known to inhibit guanine nucleotide exchange factor (GEF), GBF1, which prevents trafficking between ER and Golgi and thereby causes dissolution of the Golgi [50–55]. 3AB might also have this activity. Inhibition of ER-to-Golgi trafficking should enlarge the ERGIC, and this compartment has been implicated in genome replication [18,52]. 3AB is also known to promote invagination of membranes, an activity that could contribute to formation of vesicular clusters [56]. 3CD, on the other hand, has not been shown to perturb membrane form or function in cells. However, in cell-free extracts, the presence of 3CD promotes recruitment of ADP-ribosylation factors (ARFs) and GEFs to membranes, which could modulate vesicular trafficking and/or fusion [57,58].
Our examination of the kinetics of formation of the vesicular clusters by EG PV relative to the kinetics of genome replication was eye-opening. The kinetics of these two processes did not have the expected behavior—that is, the site of RNA synthesis forming prior to RNA synthesis (Fig 3). This unexpected kinetic behavior was not an oddity of the mutant as WT PV also exhibited this behavior (Fig 4). Our conclusion was that the vesicular clusters must not be the replication organelle. Belov and Ehrenfeld floated this possibility several years ago [9]. In reviewing the literature on formation of PV-induced vesicles, it became clear that the TEM images of others showed substantively larger vesicular clusters in spite of the fact that kinetics of genome replication and/or production of infectious virus were identical [9,11,15]. The one difference between our study and those of others was the multiplicity of infection used. We used an MOI of 10; others used an MOI of 30–50. When we increased the MOI to these higher levels, we also observed formation of larger vesicular clusters (Fig 10). These observations suggest that the appearance of vesicular cluster can be modulated by multiplicity of infection without a corresponding increase in the kinetics of virus multiplication or yield of infectious virus (S3 Fig), thus creating some ambiguity to the temporal ordering of formation of the vesicular clusters relative to replication of the genome.
Altan-Bonnet and colleagues showed that phosphatidylinositol-4-phosphate (PI4P) is induced by Coxsackievirus B3 infection and redistributes from the Golgi to sites thought to be involved in genome replication [18]. Therefore, we monitored the spatiotemporal dynamics of PI4P during PV infection. We found that the spatiotemporal dynamics of the PI4P pool was completely consistent with PI4P demarcating the replication organelle as induction and redistribution occurred well before the onset of genome replication (Fig 5A). Moreover, spatiotemporal dynamics of PI4P was delayed for EG PV (Fig 5B). Unexpectedly, PI4P induction and redistribution did not require any genome replication as these events occurred in the presence of GuHCl, a replication inhibitor. In spite of the changes to PI4P in the presence of GuHCl, Golgi integrity was not affected (Fig 6E and 6F). Therefore, PI4P dynamics and Golgi integrity are not inextricably linked. Analysis of the ultrastructure of PV-infected cells in the presence of GuHCl revealed the existence of tubules (Fig 7B). To the best of our knowledge, this observation is among the first to link translation of infecting viral genomes alone to events essential for genome replication. Under these conditions, the amount of viral proteins produced cannot be detected readily by Western blotting or immunofluorescence [43,44]. Therefore, very little of one or more viral P3 proteins or the precursor itself is sufficient to hijack cellular factors needed for production of tubules. We propose that these tubules represent the genome-replication organelle or at least the initial sites of genome replication.
We propose that 3AB, 3CD, and/or some processing intermediate thereof contribute to tubule formation and PI4P induction and/or redistribution. If this is the case, then delays in P3 processing would be expected to have an impact on PI4P dynamics. Our initial characterization of EG PV showed that its genome-replication phenotype could be complemented fully by ectopic expression of 3CD [44]. It is therefore possible that 3CD or 3CD-containing precursor alone contribute to tubule and PI4P biogenesis and dynamics. Interestingly, synthesis of PI4P by the beta isoform of the class III phosphatidylinositol-4-kinase (PI4KIIIβ), the isoform thought to be responsible for induction of PI4P by enteroviruses [18], is known to require Arf1 and GBF1 [18]. Perhaps the ability of 3CD to induce translocation of Arf1 and GBF1 from the cytoplasm to membranes may be related to its role in PI4P induction suggested here [57,58].
The delay in formation of the genome-replication organelle by EG PV created a window into the early events of this process. It was possible to visualize Golgi fragmentation, proliferation of vesicles in the area between ER and Golgi, and formation of short, thick tubules (Fig 3). These events were suggested by Altan-Bonnet and colleagues based on Golgi, ERGIC and ER marker co-localization with PI4P and CVB3 non-structural proteins and/or RNA [18]. Together, these data make a compelling case for these localized membranous structures including and between ER and Golgi representing the replication organelle.
Clues into the formation and function of PV-induced vesicular clusters were obtained from studies of GG PV. This mutant took even longer to initiate genome replication than EG PV, and this delay was attributable to an even longer delay in PI4P induction and redistribution (Fig 8). GG PV does not produce any 3AB or 3CD, which is likely the cause of this phenotype [43,44]. This mutant clearly establishes a role for P3 proteins in formation of the replication organelle. However, TEM of GG PV-infected cells revealed a cell full of tubules at times in which genome replication of GG PV RNA was occurring exponentially (Fig 7). Hints of tubulation were evident in micrographs of EG and WT PVs (Figs 3 and 4), but tubules never really accumulated. Because tubules could be trapped in WT PV-infected cells in the presence of GuHCl, our observations with GG PV-infected cells suggest that these tubules are an intermediate on path to formation of the vesicular clusters. Positive invagination of the tubules and interactions between invaginated membranes should produce vesicular clusters, as seen in cross section by TEM. As to function of the vesicular clusters, GG PV was unable to produce significant titers of infectious virus [43,44]. Our results are consistent with formation of vesicular clusters requiring 3AB and/or 3CD and facilitating virus assembly. The absence of 3AB and/or 3CD in GG PV may also preclude interactions with other PV or host proteins required for production of infectious virus. The absence of protein-protein interactions is a plausible explanation for the inability of tubular structures to fold into compact structures that appear as vesicular clusters in cross section. It is known that 3CD promotes cell-free synthesis of infectious PV [59,60]. Therefore, we propose that vesicular clusters serve as an assembly organelle.
There was a time when poliovirus non-structural proteins were considered in two categories: those that had an impact on interactions with the host; and those that had an impact on genome replication. Emphasis was often placed on shut off of host protein synthesis and biogenesis and/or remodeling of membranes by P2-encoded proteins [14,22,23,28,29,31]. P3-encoded proteins bind to the viral genome, produce the peptide/precursor used to initiate genome replication and function to replicate the genome [32,33,35–37,61–63]. This study highlights the almost unlimited functional capacity of PV non-structural proteins by now implicating P3 proteins in events both before and after genome replication. Understanding how these proteins contribute to these events requires further study. It is likely that the findings reported here for PV will apply to other picornaviruses as well.
Materials and methods
Materials
Cell culture media and supplements were from Invitrogen Life Technologies (Gibco); Difco-NZCYM for bacterial growth was from BD Biosciences; 5X Cell Culture Lysis Reagent was purchased from Promega; primary antibody against PI4P was purchased from Echelon biosciences; Alexafluor-594-IgM (goat anti-mouse) was from ThermoFisher Scientific; 16% formaldehyde, methanol-free, ultrapure was purchased from polysciences; Digitonin was from Sigma-Aldrich; Bovine Serum Albumin (BSA)-Fraction V, heat shock treated was from Fisher Bioreagents; Vectashield Antifade Mounting Medium with DAPI was from Vector Laboratories; nitrocellulose membrane was from GE Healthcare; TransIT-mRNA transfection kit was purchased from Mirus Bio LLC.
Construction of 3B-3C Gly-Gly mutant EGFP subgenomic replicon
Enhanced green fluorescence protein (EGFP) integrated subgenomic replicon plasmid, pREGFP-, was generated by replacing luciferase gene in pRLuc- [43] with EGFP. PCR was used to amplify the EGFP region using the oligonucleotides NotI-EGFP-for (5’-AAT TCG GAG CGG CCG CTG TGA GCA AGG GCG AGG AGC-3’) and EGFP-XhoI-rev (5’-GTC AGA TCC TCG AGC TTG TAC AGC TCG TCC ATG-3’) and pEGFP as a template. The PCR product replaced luciferase gene in pRLuc-GG using NotI and XhoI sites to obtain pREGFP-GG subgenomic replicon. Sequencing at the Penn State Nucleic Acid facility was used to confirm all clones.
RNA transcription
Linearization and RNA transcription were performed as described previously [43]. Briefly, the pMo-, pRLuc- and pREGFP- plasmids were linearized with EcoRI or ApaI and purified with Qiaex II bead suspension (Qiagen) following manufacture’s protocol. RNA was then transcribed from the linearized plasmid DNAs in a 20 μL reaction containing 350 mM HEPES, pH 7.5, 32 mM magnesium acetate, 40 mM dithiothreitol (DTT), 2 mM spermidine, 28 mM nucleoside triphosphates (NTPs), 0.025 μg/μL linearized DNA, and 0.025 μg/μL T7 RNA polymerase. The reaction mixture was incubated for 3 h at 37°C and magnesium pyrophosphate was removed by centrifugation for 2 min. The supernatant was transferred to a new tube and subjected to RQ1 DNase treatment (Promega) for 30 min at 37°C. RNA quality was then verified by 0.8% agarose gel electrophoresis. The RNA concentration was determined by comparing pre-known purified RNA side-by-side on an agarose gel.
Subgenomic luciferase replicon assay
Subgenomic luciferase assays were performed as described previously [43] with the following modifications. Subgenomic replicon RNA (5 μg of in vitro transcribed RNA) was electroporated into HeLa cells (American Type Culture Collection). The cells were incubated in normal growth media (DMEM/F12 supplemented with 10% fetal bovine serum, 1% penicillin/streptomycin, 5 mL/1 X 106 cells) and 1 X 105 cells were harvested and lysed using 100 μL of 1X cell culture lysis reagent (CCLR) at an indicated time post-electroporation. Luciferase activity was measured by adding an equal volume of firefly luciferase assay substrate to cell lysate and the reaction mixture was applied to a Junior LB 9509 luminometer (Berthold Technologies) to read relative light units (RLU) for 10 s. Relative light units (RLU) were then normalized based on the total protein concentration determined by Biorad protein assay reagent (BioRad) for each sample. GuHCl when used, the final concentration was 3 mM and the inhibitor was kept on cells during transfection and after, for the entire incubation period.
Total RNA preparation
One day prior to infection, 4 X 106 HeLa cells were seeded in a 100 mm dish. On the day of infection, the prepared HeLa monolayers were infected at an MOI 10 with WT or EG PV for 30 min at room temperature. Infected cells were washed once with PBS to remove unattached virus and then incubated in normal growth media (DMEM/F12 supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin) at 37°C. At the indicated times post-infection, cells were lysed with 1 mL of Trizol (Invitrogen Life Technologies) and total RNAs were purified by following manufacture’s protocol. In order to purify subgenomic replicon RNA containing total RNA, HeLa cells were transfected with subgenomic RNA as described above and 1.2 X 106 HeLa cells were lysed with 1 mL Trizol. The RNA quantity was determined using NanoDrop 1000 (ThermoFisher Scientific) and the quality was evaluated by using 0.8% agarose gel.
Northern-Blot analysis of RNA synthesis
Northern-Blot analysis was performed as described previously [44]. Briefly, the RNA was separated on a 0.6% denaturing agarose gel (0.8 M formaldehyde in 1X MOPS) by running at 120V for 2 h. The gel was washed in water for 30 min twice followed by soaking in 20X SSC (Saline Sodium Citrate) buffer for 30 min. RNA was transferred to nylon membrane (Hybond XL, GE Healthcare) using capillary blotting with 20X SSC for 16 h at room temperature. RNA was crosslinked to membrane using UV Crosslinker (Stratalinker 2400, Stratagene). The membrane was washed twice with wash buffer (1X SSC and 0.1% SDS) at 65°C for 30 min each and prehybridized in 100 mL of modified church buffer (0.5 M sodium phosphate, pH 7.2, 7% SDS, and 1 mM EDTA) for 4 h at 65°C. Hybridization was performed in a modified church buffer for 16 h at 65°C. The membrane was washed with wash buffer (1X SSC and 0.1% SDS) for 20 min at 65°C twice and once at room temperature. RNA was visualized by exposing the membrane to a phosphor screen followed by scanning the screen on a Typhoon 8600 scanner (Promega) in phosphor mode. Hybridization probe was made by PCR using oligonucleotides: 3Dseq-100-for (5’-GTT TGA AGG GGT GAA GGA A-3’) and 3Dseq-1085-rev (5'-CTC CCA TGT GAC TGT TTC AAA TG-3') and pRLuc-RA as a template. In the reaction, [α-32P]-dATP (1 mCi/mL, 3000 Ci/mmol, GE Healthcare) was used with cold dNTPs (300 μM for each dCTP, dGTP, and dTTP and 10 μM for dATP) in total 100 μl reaction. The quality of PCR product was confirmed by agarose gel electrophoresis and cpm was determined by using scintillation counter (LKB Wallac 1217 Rackbeta liquid scintillation counter).
One step growth curve assay
One day prior to infection, HeLa cells were seeded into 6-well plate at a density of 5 X 105 cells/well. On the day of infection, the prepared HeLa monolayers were washed and infected with WT or EG virus at an MOI of 10 for 30 min at room temperature. Infected cells were washed once with PBS to remove unattached virus and then incubated at 37°C. At varying times post-infection, virus was harvested from cells and media by three freeze-thaw cycles with vortexing in between. The isolated virus was quantified by plaque assay.
Virus quantification by plaque assay
For plaque assay, 0.5 X 106 HeLa cells were plated one day prior to infection in 6-well plates. On the day of infection, the media was removed and the cells were washed once in PBS. Next, the cells were infected with the 10-fold dilutions of viral supernatants previously prepared and incubated for 30 min at 37°C. The inoculum was then removed and the cells were overlaid with 1% low-melting-point agarose (EMD). The overlay was allowed to solidify for 20 min at room temperature, and the plates were incubated at 37°C for 2 days to allow for plaque formation. 30 min prior to harvesting, the overlays were incubated with 4% formaldehyde/PBS to fix virus and cells. The agarose monolayers were then removed and plaques stained with crystal violet and counted. Viral titers were calculated in PFU/mL.
Sorting subgenomic replicon expressing cells with flow cytometer
WT and GG-subgenomic replicon RNAs (2 μg of in vitro transcribed pRLuc RNA and 4 μg of in vitro transcribed pREGFP RNA) were electroporated into 1.2 X 107 HeLa cells. The cells were incubated in normal growth media at 34°C and luciferase activity was monitored. When the specific activity of luciferase was about 10,000 RLU/μg of total protein (5 h post-transfection for pRLuc-/pREGFP-WT and 14 h post-transfection for pRLuc-/pREGFP-GG), cells were harvested, chilled on ice for 5 min and sorted to collect transfection positive cells. For the sorting, EGFP positive cells were excited with a 488 Argon laser, detected with a 532/40 nm band pass filter and sorted by Cytopeia Influx sorter (Beckton-Dickinson, San Jose, CA) with 100 micron tip at 15 psi. The sorted HeLa cells were processed for transmission electron microscopy.
Transmission electron microscopy
Virus-infected HeLa cells or EGFP-positive post-sorted HeLa cells were harvested, fixed and embedded for TEM studies as described previously [44]. Briefly, the harvested cells were fixed with 1% glutaraldehyde, washed with 0.1 M cacodylate (Sodium dimethyl arsenate, Electron Microscopy Sciences) twice for 5 min each, incubated in 1% reduced osmium tetroxide containing 1% potassium ferricyanide in 0.1 M cacodylate for 60 min in the dark with one exchange and washed two times with 0.1 M cacodylate again. En bloc staining was performed with 3% uranyl acetate in 50% ethanol for 60 min in the dark. Dehydration was carried out with different concentrations of ethanol (50, 70, 95 and 100% for 5–10 min) and 100% acetonitrile. Embedding was performed overnight with 100% Epon at 65°C. The embedded sample was sectioned with a diamond knife (DiATOME) to slice 60–90 nm thickness by using ultra microtome (Reichart-Jung). The sectioned sample was place on copper grid (Electron Microscopy Science), stained with 2% uranyl acetate in 50% ethanol followed by lead citrate staining for 12 min. The grid was washed with H2O and the grid was dried completely. The image was obtained by using Jeol JEM 1200 EXII and FEI Tecnai G2 Spirit BioTwin located in Electron Microscopy Facility in Pennsylvania State University.
Immunofluorescence
2.5 X 105 cells were seeded on coverslips in 6-well plates and next day infected with WT or EG virus at an MOI of 10. GuHCl whenever used, the final concentration was 3 mM and the inhibitor was kept on cells with the virus for 30 min and for the entire incubation period thereafter. For subgenomic replicon RNA transfection, same number of cells were transfected with 2 μg pREGFP-GG RNA using the RNA transfection kit (Mirus). Infected or transfected cells were fixed with 4% formaldehyde at indicated times post-infection or transfection. Post-fixation, cells were permeabilized with 20 μM digitonin for 10 min and washed with PBS. Cells were then blocked with 3% BSA in PBS for 1 h followed by incubation with anti-PI4P (1:200) antibody for 1 h in blocking buffer. This was followed by washing with PBS and incubating with Alexafluor594; IgM (1:1000) for 1 h. Finally, the cells were washed with PBS and mounted on slides using mounting buffer with DAPI. Samples were imaged with Zeiss Axiovert 200 M epifluorescence microscope.
Construction of pSB-EGFP-2BCP3 WT and Gly-Gly (GG) mutant plasmid constructs
The T7-Kozak-GFP region was amplified using the oligonucleotides EcoRI-Koz-EGFP-for (5’- TAG GCT AGC CTC GAG AATTC GCC ACC ATG GTG TCA AAA GGA GAG GAG C-3’) and EGFP-rev (5’-TAT GTA ATT GGT GAT GCC CTG GAA TAA TGC CTC GAG AGC-3’) and pMo-EGFP as a template. PV 2BCP3 region was amplified from pMo-WT and pMo-GG templates [44] using the oligonucleotides PV-for (5’-GCT CTC GAG GCA TTA TTC CAG GGC ATC ACC AAT TAC ATA-3’) and P3-rev (5’-TAT GTA ATT GGT GAT GCC CTG GAA TAA TGC CTC GAG AGC-3’). The T7-Kozak-EGFP and 2BCP3 (WT and GG) regions were joined by overlap extension PCR. The resulting EGFP-2BCP3 fragments were cloned into a modified pIRES plasmid (Clontech) referred to as pSB by inserting between the EcoR I and Not I unique sites using InFusion (Clontech). Sequencing at the Penn State Nucleic Acid facility was used to confirm all clones.
RNA capping and polyadenylation
The in vitro transcribed pSB-RNAs were purified using the RNeasy kit (Qiagen) using the manufacturer’s protocol and subjected to modification by adding a 5’-end cap and a 3’-end poly(A) tail using the T7 mRNA production kit (Cellscript) following the manufacturer’s protocol. The modified RNAs were further purified using the RNeasy columns and quality was checked by evaluating samples on a 0.8% agarose gel. The addition of poly(A) tail was confirmed by comparing the modified RNA to unmodified RNA. RNAs (5 μg of in vitro transcribed RNA) were electroporated into HeLa cells, cells harvested at 12 h post-electroporation, GFP expression confirmed by fluorescence microscopy and cells were processed for Western blotting [44] and TEM.
Supporting information
Data Availability
All relevant data are within the paper and its Supporting Information files.
Funding Statement
This study was funded by grant AI053531 from the National Institute of Allergy and Infectious Diseases, National Institutes of Health (https://www.niaid.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
References
- 1.Holmes EC, Drummond AJ (2007) The evolutionary genetics of viral emergence. Curr Top Microbiol Immunol 315: 51–66. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Aguilera ER, Erickson AK, Jesudhasan PR, Robinson CM, Pfeiffer JK (2017) Plaques Formed by Mutagenized Viral Populations Have Elevated Coinfection Frequencies. MBio 8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Korboukh VK, Lee CA, Acevedo A, Vignuzzi M, Xiao Y, et al. (2014) RNA virus population diversity, an optimum for maximal fitness and virulence. J Biol Chem 289: 29531–29544. doi: 10.1074/jbc.M114.592303 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Bird SW, Maynard ND, Covert MW, Kirkegaard K (2014) Nonlytic viral spread enhanced by autophagy components. Proc Natl Acad Sci U S A 111: 13081–13086. doi: 10.1073/pnas.1401437111 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Chen YH, Du W, Hagemeijer MC, Takvorian PM, Pau C, et al. (2015) Phosphatidylserine vesicles enable efficient en bloc transmission of enteroviruses. Cell 160: 619–630. doi: 10.1016/j.cell.2015.01.032 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Robinson CM, Jesudhasan PR, Pfeiffer JK (2014) Bacterial lipopolysaccharide binding enhances virion stability and promotes environmental fitness of an enteric virus. Cell Host Microbe 15: 36–46. doi: 10.1016/j.chom.2013.12.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.den Boon JA, Ahlquist P (2010) Organelle-like membrane compartmentalization of positive-strand RNA virus replication factories. Annu Rev Microbiol 64: 241–256. doi: 10.1146/annurev.micro.112408.134012 [DOI] [PubMed] [Google Scholar]
- 8.Belov GA, Sztul E (2014) Rewiring of cellular membrane homeostasis by picornaviruses. J Virol 88: 9478–9489. doi: 10.1128/JVI.00922-14 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Belov GA, Nair V, Hansen BT, Hoyt FH, Fischer ER, et al. (2012) Complex dynamic development of poliovirus membranous replication complexes. J Virol 86: 302–312. doi: 10.1128/JVI.05937-11 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Bienz K, Egger D, Pfister T, Troxler M (1992) Structural and functional characterization of the poliovirus replication complex. J Virol 66: 2740–2747. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Bienz K, Egger D, Rasser Y, Bossart W (1980) Kinetics and location of poliovirus macromolecular synthesis in correlation to virus-induced cytopathology. Virology 100: 390–399. [DOI] [PubMed] [Google Scholar]
- 12.Kallman F, Williams RC, Dulbecco R, Vogt M (1958) Fine structure of changes produced in cultured cells sampled at specified intervals during a single growth cycle of polio virus. J Biophys Biochem Cytol 4: 301–308. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Schlegel A, Giddings TH Jr., Ladinsky MS, Kirkegaard K (1996) Cellular origin and ultrastructure of membranes induced during poliovirus infection. J Virol 70: 6576–6588. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Bienz K, Egger D, Pasamontes L (1987) Association of polioviral proteins of the P2 genomic region with the viral replication complex and virus-induced membrane synthesis as visualized by electron microscopic immunocytochemistry and autoradiography. Virology 160: 220–226. [DOI] [PubMed] [Google Scholar]
- 15.Bienz K, Egger D, Rasser Y, Bossart W (1983) Intracellular distribution of poliovirus proteins and the induction of virus-specific cytoplasmic structures. Virology 131: 39–48. [DOI] [PubMed] [Google Scholar]
- 16.Bienz K, Egger D, Troxler M, Pasamontes L (1990) Structural organization of poliovirus RNA replication is mediated by viral proteins of the P2 genomic region. J Virol 64: 1156–1163. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Troxler M, Egger D, Pfister T, Bienz K (1992) Intracellular localization of poliovirus RNA by in situ hybridization at the ultrastructural level using single-stranded riboprobes. Virology 191: 687–697. [DOI] [PubMed] [Google Scholar]
- 18.Hsu NY, Ilnytska O, Belov G, Santiana M, Chen YH, et al. (2010) Viral reorganization of the secretory pathway generates distinct organelles for RNA replication. Cell 141: 799–811. doi: 10.1016/j.cell.2010.03.050 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Racaniello VR (2013) Picornaviridae: the viruses and their replication In: Knipe DM, Howley PM, editors. Fields virology. 6th ed. Philadelphia, PA: Lippincott Williams & Wilkins; pp. 453–489. [Google Scholar]
- 20.Asare E, Mugavero J, Jiang P, Wimmer E, Paul AV (2016) A Single Amino Acid Substitution in Poliovirus Nonstructural Protein 2CATPase Causes Conditional Defects in Encapsidation and Uncoating. J Virol 90: 6174–6186. doi: 10.1128/JVI.02877-15 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Baltera RF Jr., Tershak DR (1989) Guanidine-resistant mutants of poliovirus have distinct mutations in peptide 2C. J Virol 63: 4441–4444. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Cho MW, Teterina N, Egger D, Bienz K, Ehrenfeld E (1994) Membrane rearrangement and vesicle induction by recombinant poliovirus 2C and 2BC in human cells. Virology 202: 129–145. doi: 10.1006/viro.1994.1329 [DOI] [PubMed] [Google Scholar]
- 23.Haghighat A, Svitkin Y, Novoa I, Kuechler E, Skern T, et al. (1996) The eIF4G-eIF4E complex is the target for direct cleavage by the rhinovirus 2A proteinase. J Virol 70: 8444–8450. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Li JP, Baltimore D (1988) Isolation of poliovirus 2C mutants defective in viral RNA synthesis. J Virol 62: 4016–4021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Li JP, Baltimore D (1990) An intragenic revertant of a poliovirus 2C mutant has an uncoating defect. J Virol 64: 1102–1107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Liu Y, Wang C, Mueller S, Paul AV, Wimmer E, et al. (2010) Direct interaction between two viral proteins, the nonstructural protein 2C and the capsid protein VP3, is required for enterovirus morphogenesis. PLoS Pathog 6: e1001066 doi: 10.1371/journal.ppat.1001066 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Pincus SE, Diamond DC, Emini EA, Wimmer E (1986) Guanidine-selected mutants of poliovirus: mapping of point mutations to polypeptide 2C. J Virol 57: 638–646. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Suhy DA, Giddings TH Jr., Kirkegaard K (2000) Remodeling the endoplasmic reticulum by poliovirus infection and by individual viral proteins: an autophagy-like origin for virus-induced vesicles. J Virol 74: 8953–8965. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Teterina NL, Gorbalenya AE, Egger D, Bienz K, Ehrenfeld E (1997) Poliovirus 2C protein determinants of membrane binding and rearrangements in mammalian cells. J Virol 71: 8962–8972. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Vance LM, Moscufo N, Chow M, Heinz BA (1997) Poliovirus 2C region functions during encapsidation of viral RNA. J Virol 71: 8759–8765. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Ventoso I, MacMillan SE, Hershey JW, Carrasco L (1998) Poliovirus 2A proteinase cleaves directly the eIF-4G subunit of eIF-4F complex. FEBS Lett 435: 79–83. [DOI] [PubMed] [Google Scholar]
- 32.Andino R, Rieckhof GE, Achacoso PL, Baltimore D (1993) Poliovirus RNA synthesis utilizes an RNP complex formed around the 5'-end of viral RNA. Embo j 12: 3587–3598. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Gamarnik AV, Andino R (1998) Switch from translation to RNA replication in a positive-stranded RNA virus. Genes Dev 12: 2293–2304. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Giachetti C, Hwang SS, Semler BL (1992) cis-acting lesions targeted to the hydrophobic domain of a poliovirus membrane protein involved in RNA replication. J Virol 66: 6045–6057. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Hope DA, Diamond SE, Kirkegaard K (1997) Genetic dissection of interaction between poliovirus 3D polymerase and viral protein 3AB. J Virol 71: 9490–9498. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Parsley TB, Towner JS, Blyn LB, Ehrenfeld E, Semler BL (1997) Poly (rC) binding protein 2 forms a ternary complex with the 5'-terminal sequences of poliovirus RNA and the viral 3CD proteinase. Rna 3: 1124–1134. [PMC free article] [PubMed] [Google Scholar]
- 37.Paul AV, Rieder E, Kim DW, van Boom JH, Wimmer E (2000) Identification of an RNA hairpin in poliovirus RNA that serves as the primary template in the in vitro uridylylation of VPg. J Virol 74: 10359–10370. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Rieder E, Paul AV, Kim DW, van Boom JH, Wimmer E (2000) Genetic and biochemical studies of poliovirus cis-acting replication element cre in relation to VPg uridylylation. J Virol 74: 10371–10380. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Nicklin MJ, Harris KS, Pallai PV, Wimmer E (1988) Poliovirus proteinase 3C: large-scale expression, purification, and specific cleavage activity on natural and synthetic substrates in vitro. J Virol 62: 4586–4593. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Toyoda H, Nicklin MJ, Murray MG, Anderson CW, Dunn JJ, et al. (1986) A second virus-encoded proteinase involved in proteolytic processing of poliovirus polyprotein. Cell 45: 761–770. [DOI] [PubMed] [Google Scholar]
- 41.Ypma-Wong MF, Semler BL (1987) In vitro molecular genetics as a tool for determining the differential cleavage specificities of the poliovirus 3C proteinase. Nucleic Acids Res 15: 2069–2088. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Lawson MA, Semler BL (1992) Alternate poliovirus nonstructural protein processing cascades generated by primary sites of 3C proteinase cleavage. Virology 191: 309–320. [DOI] [PubMed] [Google Scholar]
- 43.Pathak HB, Oh HS, Goodfellow IG, Arnold JJ, Cameron CE (2008) Picornavirus genome replication: roles of precursor proteins and rate-limiting steps in oriI-dependent VPg uridylylation. J Biol Chem 283: 30677–30688. doi: 10.1074/jbc.M806101200 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Oh HS, Pathak HB, Goodfellow IG, Arnold JJ, Cameron CE (2009) Insight into poliovirus genome replication and encapsidation obtained from studies of 3B-3C cleavage site mutants. J Virol 83: 9370–9387. doi: 10.1128/JVI.02076-08 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Jurgens C, Flanegan JB (2003) Initiation of poliovirus negative-strand RNA synthesis requires precursor forms of p2 proteins. J Virol 77: 1075–1083. doi: 10.1128/JVI.77.2.1075-1083.2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Novak JE, Kirkegaard K (1994) Coupling between genome translation and replication in an RNA virus. Genes Dev 8: 1726–1737. [DOI] [PubMed] [Google Scholar]
- 47.Towner JS, Mazanet MM, Semler BL (1998) Rescue of defective poliovirus RNA replication by 3AB-containing precursor polyproteins. J Virol 72: 7191–7200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Sandoval IV, Carrasco L (1997) Poliovirus infection and expression of the poliovirus protein 2B provoke the disassembly of the Golgi complex, the organelle target for the antipoliovirus drug Ro-090179. J Virol 71: 4679–4693. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Harki DA, Graci JD, Galarraga JE, Chain WJ, Cameron CE, et al. (2006) Synthesis and antiviral activity of 5-substituted cytidine analogues: identification of a potent inhibitor of viral RNA-dependent RNA polymerases. J Med Chem 49: 6166–6169. doi: 10.1021/JM060872x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Belov GA, Altan-Bonnet N, Kovtunovych G, Jackson CL, Lippincott-Schwartz J, et al. (2007) Hijacking components of the cellular secretory pathway for replication of poliovirus RNA. J Virol 81: 558–567. doi: 10.1128/JVI.01820-06 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Choe SS, Dodd DA, Kirkegaard K (2005) Inhibition of cellular protein secretion by picornaviral 3A proteins. Virology 337: 18–29. doi: 10.1016/j.virol.2005.03.036 [DOI] [PubMed] [Google Scholar]
- 52.Doedens JR, Giddings TH Jr., Kirkegaard K (1997) Inhibition of endoplasmic reticulum-to-Golgi traffic by poliovirus protein 3A: genetic and ultrastructural analysis. J Virol 71: 9054–9064. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Doedens JR, Kirkegaard K (1995) Inhibition of cellular protein secretion by poliovirus proteins 2B and 3A. Embo j 14: 894–907. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Wessels E, Duijsings D, Lanke KH, van Dooren SH, Jackson CL, et al. (2006) Effects of picornavirus 3A Proteins on Protein Transport and GBF1-dependent COP-I recruitment. J Virol 80: 11852–11860. doi: 10.1128/JVI.01225-06 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Wessels E, Duijsings D, Niu TK, Neumann S, Oorschot VM, et al. (2006) A viral protein that blocks Arf1-mediated COP-I assembly by inhibiting the guanine nucleotide exchange factor GBF1. Dev Cell 11: 191–201. doi: 10.1016/j.devcel.2006.06.005 [DOI] [PubMed] [Google Scholar]
- 56.Wang J, Ptacek JB, Kirkegaard K, Bullitt E (2013) Double-membraned liposomes sculpted by poliovirus 3AB protein. J Biol Chem 288: 27287–27298. doi: 10.1074/jbc.M113.498899 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Belov GA, Fogg MH, Ehrenfeld E (2005) Poliovirus proteins induce membrane association of GTPase ADP-ribosylation factor. J Virol 79: 7207–7216. doi: 10.1128/JVI.79.11.7207-7216.2005 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Belov GA, Habbersett C, Franco D, Ehrenfeld E (2007) Activation of cellular Arf GTPases by poliovirus protein 3CD correlates with virus replication. J Virol 81: 9259–9267. doi: 10.1128/JVI.00840-07 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Franco D, Pathak HB, Cameron CE, Rombaut B, Wimmer E, et al. (2005) Stimulation of poliovirus synthesis in a HeLa cell-free in vitro translation-RNA replication system by viral protein 3CDpro. J Virol 79: 6358–6367. doi: 10.1128/JVI.79.10.6358-6367.2005 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Franco D, Pathak HB, Cameron CE, Rombaut B, Wimmer E, et al. (2005) Stimulation of poliovirus RNA synthesis and virus maturation in a HeLa cell-free in vitro translation-RNA replication system by viral protein 3CDpro. Virol J 2: 86 doi: 10.1186/1743-422X-2-86 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Andino R, Rieckhof GE, Baltimore D (1990) A functional ribonucleoprotein complex forms around the 5' end of poliovirus RNA. Cell 63: 369–380. [DOI] [PubMed] [Google Scholar]
- 62.Cornell CT, Semler BL (2002) Subdomain specific functions of the RNA polymerase region of poliovirus 3CD polypeptide. Virology 298: 200–213. [DOI] [PubMed] [Google Scholar]
- 63.Paul AV, van Boom JH, Filippov D, Wimmer E (1998) Protein-primed RNA synthesis by purified poliovirus RNA polymerase. Nature 393: 280–284. doi: 10.1038/30529 [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
All relevant data are within the paper and its Supporting Information files.